相关实验视频

Updated: Jan 12, 2026

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

RECQL4作为一种针对卵巢癌的新型药物标

Yuankun Qin¹, Lanlan Li², Jia Yu²

¹Department of Obstetrics and Gynecology, Affiliated Hospital of Guizhou Medical University, Guiyang 550002, China; State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Guizhou Medical University, Guiyang 550014, China.

Biochemical pharmacology

|November 7, 2025

概括

研究人员确定了RecQ样酶4 (RECQL4) 作为卵巢癌的标. 一种传统中医药化合物TC12-1抑制RECQL4,减少瘤生长和转移,毒性最小.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
药理学药理学是指药理学的学科.

背景情况:

卵巢癌带来了诊断挑战和糟糕的结果.
确定新的治疗点和药物对于改善患者预后至关重要.
RecQ样酶4 (RECQL4) 表达与卵巢癌恶性和预后相关.

研究的目的:

研究RECQL4作为高度血清性卵巢癌 (HGSC) 的治疗点.
选和评估一种针对RECQL4的新型化合物,用于卵巢癌治疗.

主要方法:

对HGSC患者的组织分析,以将RECQL4表达与临床数据相关联.
对中国传统医学图书馆进行查,以确定RECQL4抑制剂.
在体外测试以评估已识别的化合物 (TC12-1) 的抗癌作用.
使用小鼠模型进行体内研究,以评估瘤抑制和毒性.

主要成果:

RECQL4表达与HGSC恶性瘤增加和预后较差有关.
化坦辛类似物 (TC12-1) 被确定为一种强大的RECQL4抑制剂.
TC12-1诱导了亡,抑制了侵袭和转移,并在癌细胞中引起了DNA损伤.
在体内,TC12-1表现出显著的瘤生长抑制,没有主要的器官毒性.

结论:

RECQL4是卵巢癌的一个有前途的治疗点.
TC12-1显示出作为治疗卵巢癌的有效和安全药物的潜力.
用TC12-1准RECQL4会影响细胞周期和DNA复制途径,提供一种新的治疗策略.

更多相关视频

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...